Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2003 | 2 |
2012 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults.
Clin Vaccine Immunol. 2012 Oct;19(10):1651-60. doi: 10.1128/CVI.00258-12. Epub 2012 Aug 22.
Clin Vaccine Immunol. 2012.
PMID: 22914365
Free PMC article.
Clinical Trial.
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.
Gilbert PB, DeGruttola VG, Hudgens MG, Self SG, Hammer SM, Corey L.
Gilbert PB, et al.
J Infect Dis. 2003 Jul 15;188(2):179-93. doi: 10.1086/376449. Epub 2003 Jul 1.
J Infect Dis. 2003.
PMID: 12854072
Item in Clipboard
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.
Tierney C, Lathey JL, Christopherson C, Bettendorf DM, D'Aquila RT, Hammer SM, Katzenstein DA.
Tierney C, et al.
J Infect Dis. 2003 Jan 1;187(1):144-8. doi: 10.1086/345870. Epub 2002 Dec 13.
J Infect Dis. 2003.
PMID: 12508159
Clinical Trial.
Item in Clipboard
Cite
Cite